Key Metrics
CiteScore 

5.3
Impact Factor 

< 5
SJR 

Q3Endocrinology, Diabetes and Metabolism

SNIP 

1.33
Recommended pre-submission checks
Powered by 

Topics Covered on Therapeutic Advances in Endocrinology and Metabolism
Therapeutic Advances in Endocrinology and Metabolism Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2300 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Therapeutic Advances in Endocrinology and Metabolism ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Therapeutic Advances in Endocrinology and Metabolism
Beyond glycemic control: clinical cardiovascular effects of tirzepatide\u2014a narrative review
- 28 Jul 2026
- Therapeutic Advances in Endocrinology and Metabolism
GLP-1 receptor agonists in primary care: readiness, equity, and the risk of a two-tiered obesity treatment landscape
- 27 Jul 2026
- Therapeutic Advances in Endocrinology and Metabolism
Automated insulin delivery use in a woman living with type 1 diabetes on peritoneal dialysis: a case report
- 16 Jul 2026
- Therapeutic Advances in Endocrinology and Metabolism
Determination of the relationship between raftlin, oxidative stress levels, and vitamin D receptor gene polymorphism in diabetic patients
- 15 Jul 2026
- Therapeutic Advances in Endocrinology and Metabolism
Diabetes-type-specific thyroid safety of GLP-1 receptor agonists: evidence from a large real-world cohort
- 30 Jun 2026
- Therapeutic Advances in Endocrinology and Metabolism
Association of prediabetes phenotypes with metabolic dysfunction-associated fatty liver disease and liver fibrosis: a population-based study
- 11 Jun 2026
- Therapeutic Advances in Endocrinology and Metabolism
Beyond glycemic control: clinical cardiovascular effects of tirzepatide\u2014a narrative review
- 28 Jul 2026
- Therapeutic Advances in Endocrinology and Metabolism
GLP-1 receptor agonists in primary care: readiness, equity, and the risk of a two-tiered obesity treatment landscape
- 27 Jul 2026
- Therapeutic Advances in Endocrinology and Metabolism
Automated insulin delivery use in a woman living with type 1 diabetes on peritoneal dialysis: a case report
- 16 Jul 2026
- Therapeutic Advances in Endocrinology and Metabolism
Determination of the relationship between raftlin, oxidative stress levels, and vitamin D receptor gene polymorphism in diabetic patients
- 15 Jul 2026
- Therapeutic Advances in Endocrinology and Metabolism
Diabetes-type-specific thyroid safety of GLP-1 receptor agonists: evidence from a large real-world cohort
- 30 Jun 2026
- Therapeutic Advances in Endocrinology and Metabolism
Association of prediabetes phenotypes with metabolic dysfunction-associated fatty liver disease and liver fibrosis: a population-based study
- 11 Jun 2026
- Therapeutic Advances in Endocrinology and Metabolism